Ted William Karkus, a major owner of ProPhase Labs and ProPhase Labs's CEO & Chairman and a director of the company, just received 600,000 options from the company. The strike price of the options received was $2.00, and these expire on April 27, 2024. Karkus now owns at least 600,000 options on the company.
Some additional info was provided as follows:
The transaction reported in this row involves a grant by the Issuer to the Reporting Person of options to purchase the Issuer's common stock that will vest in four equal annual installments beginning April 26, 2018, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of April 27, 2017.
The above information was disclosed in a fi ling to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever ProPhase Labs makes a similar move, sign up!
Other recent filings from the company include the following:
BML Investment Partners, L.P. just provided an update on share ownership of ProPhase Labs - Jan. 30, 2018
ProPhase Labs's Chief Accounting Officer just declared owning 7,428 shares of ProPhase Labs - Jan. 23, 2018